ARCHIVES

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

NCI Cooperative Group, Cancer Center Trials Listed

March 28, 2008

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989

NAS To Honor Outstanding Scientists

February 28, 1997

NCI Proposed 1980 Budget Increases R01 Grants By $50 Million Over ’79; Total – $1.055 Billion

June 9, 1978

Judge Clears Way For Trial Pitting FDA Against Physicians Over First Amendment

March 24, 1995